Pharmacogenomics Informed Medications Management Service

Concepts

• pharmacy services
• pharmacogenomics informed medications management service
• support service for nhs
• edinburgh
• pharmaceutical clinical decision support service
• medical device regulations
• integrated pharmacogenomics
• medical device
• medications management service
• introductory information document

Location

All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014

Description

This requirement is to identify an Innovation Partner who will develop an integrated Pharmacogenomics and Pharmaceutical Clinical Decision Support Service for NHS Scotland which will safely identify patients at greatest risk of harm from multiple medication and produce an efficient, safe and effective medication regime that is tailored to meet their changing needs.

Total Quantity or Scope

The Authority is procuring the provision of an integrated pharmacogenomics and pharmaceutical clinical decision support service which will safely identify patients at greatest risk of harm from multiple medication and produce an efficient, safe and effective medication regime that is tailored to meet the patient’s changing needs. The developed solution will need to comply with any and all regulatory requirements. The solution to be developed by the tenderers should aim to provide enabling tools to implement pharmacogenetic testing and integration into electronic health records and clinical decision support systems, comprising, but not limited to: - Pharmacogenetic panel - Clinical decision support system that is approved and regulated in line with the medical device regulations and any subsequent requirements that may be produced for operating within the United Kingdom. Tenderers will be responsible for registering and managing the developed software as a medical device (SAMD) for the duration of the awarded framework agreement and for elements of Phase 2c of the Procurement (please see the Invitation to Tender – Introductory Information document for details of the Procurement phases) as required and deemed by the Authority (if available). - Technology to integrate into primary and secondary care electronic health record systems, and the resource to support the integration into each of the Authority and Participating Authorities systems as outlined in the ITT and Associated Documentation. - An education programme for the purpose of improving clinicians and pharmacists’ confidence and familiarity with pharmacogenomics and also to support public understanding and acceptance. The Project will consist of 2 phases. Phase 1 will consist of an appropriately powered patient trial (circa 10,000 to 20,000 patients) at Greater Glasgow and Clyde which must be delivered within 30 months or less from the award date of the contract. Phase 1 will determine the clinical and economic viability of the project. Following completion of Phase 1 the Authority will either: terminate the agreement; extend into Phase 2 with no change to the agreement; Re-negotiate a number of points with the Innovation Partner and enter into Phase 2. Any renegotiation of the Framework Agreement following phase 1 will be in line with Regulation 72 of The Public Contracts (Scotland) Regulations 2015. Phase 2 is the potential widespread adoption of the service across NHS Scotland. The Authority intends to award a framework agreement to one (1) supplier (being the successful tenderer who will become the “Contractor”), however the Authority reserves the right to award a place on the above noted framework agreement to more than one supplier. Full details of the Service can be found within the PIMM documentation which is included in the PQQ/ITT. Additional information: this is an Innovation Partnership Procurement

Renewal Options

This framework includes the option to extend for up to a total period of thirty (30) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Award Criteria

CPV Codes

• 85149000 - Pharmacy services

Indicators

• This is a one-off contract (no recurrence)
• Renewals are available.
• Financial restrictions apply.
• Professional qualifications are sought.
• Technical restrictions apply.

Legal Justification

This Innovation partnership procurement wil result in a framework more than 5 years due the complex R&D required to produced the final arrangement. Considerable change management and review will be required to migrate to another supplier without impacting on patient outcomes

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** The estimated value referred to in Section II.1.5 and II.2.6 covers the sixty (60) month contract duration and the thirty (30) month extension period of the framework agreement. The buyer is using PCS-Tender to conduct this PQQ exercise. The Project code is 19929. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2343 The Contracting Authority does not intend to include a sub-contract clause as part of community benefits (as per Section 25 of the Procurement Reform (Scotland) Act 2014) in this contract for the following reason: Framework Agreement Terms 23.1 Subject to Clause 23.2 neither Party shall be entitled to assign, novate or otherwise dispose of any or all of its rights and obligations under this Framework Agreement without the prior written consent of the other Party, neither may the Contractor subcontract the whole or any part of its obligations under this Framework Agreement except with the express prior written consent of the Authority. 23.2 The Authority shall be entitled to novate the Framework Agreement to any other body which substantially performs any of the functions that previously had been performed by the Authority. Community benefits are included in this requirement. For more information see: https://www.gov.scot/policies/public-sector-procurement/community-benefits-in-pr... A summary of the expected community benefits has been provided as follows: Community Benefits - 'Community Benefits' in this framework context are contractual requirements which deliver a wider social benefit in addition to the core purpose of the contract. Examples of Community Benefits - Community activity – investment in buildings, resources, facilities, (new or repair), human resources - Supporting education, learning, schools – school visits, presentations, providing resources, factory / site visits, education, training and learning - Employment – supporting via apprentices, employing unemployed, training, skills development, supporting return to work - Economic – support SMEs, 3rd sector / supported business indirectly, directly or via sub-contracting - In particular, requirements which the authority is particularly interested in for this framework relate to targeted training and recruitment. The Authority is interested in opportunities for the long term unemployed, those not in education, employment or training employment, addressing barriers to employment and personal development through vocational qualifications. Mandatory Requirement Tenderers must agree to support the concept, provision and ongoing development of community benefits provision in relation to developing the solution. Tenderers will be asked to participate in and support a process of ongoing contract and supplier development of community benefits - including the tracking and reporting of community benefits delivered as part of this procurement and contract. This will also include the community benefit gateway that National Procurement have launched identifying projects of interest across Scotland related to health improvements and local community benefit. Further details can be found on the Public Health Scotland Community Benefits Gateway (https://www.publichealthscotland.scot/our-organisation/procurement/community-ben...). (SC Ref:657797)